Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Hologic, Inc.    HOLX   US4364401012

HOLOGIC, INC. (HOLX)

11
Delayed Quote. Delayed Nasdaq - 03/04 04:14:59 pm
32.355 USD   -0.64%
02/04 HOLOGIC : to Present at Three Upcoming Investor Conferences
01/28 HOLOGIC : beats Street 1Q forecasts
01/28 HOLOGIC : Announces Financial Results for First Quarter Fiscal 2015
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Hologic, Inc. : Hologic to Present at Three Upcoming Investor Conferences

05/09/2013 | 07:05am US/Eastern

BEDFORD, Mass., May 9, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that company management will participate in the following investor conferences:

    --  Glenn Muir, Executive Vice President and Chief Financial Officer, will
        present at:
        --  The Bank of America Merrill Lynch 2013 Health Care Conference in Las
            Vegas, Nevada on Tuesday, May 14, 2013 at 11:40 a.m. Eastern Time
            (ET).
        --  The William Blair 33(rd) Annual Growth Stock Conference in Chicago,
            Illinois on Wednesday, June 12, 2013 at 1:40 p.m. ET.
    --  Rob Cascella, President and Chief Executive Officer, will present at:
        --  The Goldman Sachs 34(th) Annual Global Healthcare Conference in
            Rancho Palos Verdes, California on Wednesday, June 12, 2013 at 2:20
            p.m. ET.

Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at www.hologic.com/investors-overview. Archives of the presentations will be available for replay following the conferences.

About Hologic, Inc.:

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.


    Contacts:


    Deborah R. Gordon                  Al Kildani

    Vice President, Investor Relations Senior Director, Investor Relations

    (781) 999-7716                     (858) 410-8653

    deborah.gordon@hologic.com         al.kildani@hologic.com

SOURCE Hologic, Inc.

React to this article
Latest news on HOLOGIC, INC.
03/04 HOLOGIC : Submission of Matters to a Vote of Security Holders (form 8-K)
02/25 HOLOGIC : Patent Issued for Decorrelated Channel Sampling for Digital Imaging
02/24 HOLOGIC : Tepnel Pharma Services Expands Portfolio to Include Companion Diagnost..
02/24 HOLOGIC : Sources Sought Notice - J-- Hologic Mammography M&R Follow-On ELP
02/19 HOLOGIC : Special Notice - 65-- (WLR) MYOSURE CONTROL UNIT W/FOOT PEDAL
02/16 HOLOGIC : Combine Solicitation - EVIVA PROBES
02/14 HOLOGIC : MILITARY Probes Sought by U.S. Navy
02/12 HOLOGIC : Patent Application Titled "Mri Display Output Reflecting Contrast Agen..
02/12 HOLOGIC : Patent Issued for Mammography System and Method Employing Offset Compr..
02/04 HOLOGIC : to Present at Three Upcoming Investor Conferences
Dynamic quotes  
ON
| OFF